{
  "patient_details": {
    "name": "piyush",
    "age": 30,
    "gender": "male",
    "symptoms": "Hematuria, Proteinuria, Edema, High blood pressure, Flank pain, Lower back pain, Fatigue, Changes in urine color, Uremia, Nausea, Vomiting, Loss of appetite",
    "duration": "2 years",
    "family_history": "No",
    "medications": "yes for headache, loss of appetite",
    "previous_diagnoses": "no",
    "travel": "no",
    "allergies": "yes with milk",
    "other_conditions": ""
  },
  "top_rare_diseases": [
    {
      "disease_name": "Alport Syndrome",
      "score": 0.85,
      "description": "A rare genetic disorder characterized by kidney disease, hearing loss, and eye abnormalities.",
      "overview": "Alport syndrome is a genetic disorder that affects the type IV collagen found in the body's basement membranes, crucial for kidney, inner ear, and eye function.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "Hearing loss",
        "Eye abnormalities"
      ],
      "clinical_significance": "Alport syndrome can lead to end-stage kidney disease and requires monitoring of kidney function, blood pressure, and hearing.",
      "causes": "Mutations in the COL4A3, COL4A4, or COL4A5 genes.",
      "related_disorders": [
        "Goodpasture syndrome",
        "Thin basement membrane disease"
      ],
      "diagnosis": "Genetic testing, kidney biopsy, hearing tests, and eye examinations.",
      "treatment": "Management of symptoms, dialysis or kidney transplant for end-stage kidney disease, and hearing aids for hearing loss.",
      "clinical_trials": [
        "NCT01492677",
        "NCT03182649"
      ],
      "key_aspects": [
        "Genetic basis",
        "Multisystem involvement",
        "Risk of progression to kidney failure"
      ]
    },
    {
      "disease_name": "Focal Segmental Glomerulosclerosis (FSGS)",
      "score": 0.78,
      "description": "A rare kidney disease characterized by scarring of the glomeruli.",
      "overview": "FSGS can be primary (idiopathic) or secondary due to another disease or condition. It leads to nephrotic syndrome.",
      "signs_symptoms": [
        "Proteinuria",
        "Edema",
        "Hematuria",
        "Fatigue"
      ],
      "clinical_significance": "FSGS can lead to kidney failure and requires aggressive management.",
      "causes": "Primary (unknown cause), genetic mutations, or secondary to another condition.",
      "related_disorders": [
        "Minimal change disease",
        "Membranous nephropathy"
      ],
      "diagnosis": "Kidney biopsy, blood tests, and urine tests.",
      "treatment": "Corticosteroids, immunosuppressants, and supportive care; dialysis or kidney transplant for advanced disease.",
      "clinical_trials": [
        "NCT03500311",
        "NCT03673267"
      ],
      "key_aspects": [
        "Risk of progression to kidney failure",
        "Variability in presentation and response to treatment"
      ]
    },
    {
      "disease_name": "IgA Nephropathy (Berger's Disease)",
      "score": 0.72,
      "description": "A kidney disease characterized by deposits of IgA antibodies in the glomeruli.",
      "overview": "IgA nephropathy can cause hematuria and proteinuria, progressing to kidney failure in some cases.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "Fatigue"
      ],
      "clinical_significance": "IgA nephropathy is a leading cause of kidney disease worldwide.",
      "causes": "Deposits of IgA antibodies in the glomeruli, often following a respiratory or gastrointestinal infection.",
      "related_disorders": [
        "Henoch-Sch\u00f6nlein purpura",
        "Goodpasture syndrome"
      ],
      "diagnosis": "Kidney biopsy, blood tests, and urine tests.",
      "treatment": "Management of blood pressure and proteinuria; immunosuppressive therapy in some cases; dialysis or kidney transplant for advanced disease.",
      "clinical_trials": [
        "NCT03212499",
        "NCT02932503"
      ],
      "key_aspects": [
        "Variable prognosis",
        "Risk of progression to kidney failure"
      ]
    },
    {
      "disease_name": "Membranoproliferative Glomerulonephritis (MPGN)",
      "score": 0.68,
      "description": "A rare kidney disease characterized by changes in the glomeruli.",
      "overview": "MPGN can be caused by infections, autoimmune disorders, or genetic mutations.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "Fatigue"
      ],
      "clinical_significance": "MPGN can lead to kidney failure and requires monitoring and management.",
      "causes": "Infections (e.g., hepatitis B and C), autoimmune disorders, or genetic mutations.",
      "related_disorders": [
        "FSGS",
        "IgA nephropathy"
      ],
      "diagnosis": "Kidney biopsy, blood tests, and urine tests.",
      "treatment": "Management of underlying cause, supportive care, and immunosuppressive therapy; dialysis or kidney transplant for advanced disease.",
      "clinical_trials": [
        "NCT03154365",
        "NCT02723519"
      ],
      "key_aspects": [
        "Heterogeneous causes and presentation",
        "Risk of progression to kidney failure"
      ]
    },
    {
      "disease_name": "C3 Glomerulopathy",
      "score": 0.62,
      "description": "A rare kidney disease characterized by abnormal activation of the complement system.",
      "overview": "C3 glomerulopathy includes dense deposit disease and C3 glomerulonephritis.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "Fatigue"
      ],
      "clinical_significance": "C3 glomerulopathy can lead to kidney failure.",
      "causes": "Abnormal activation of the complement system, often due to genetic mutations.",
      "related_disorders": [
        "MPGN",
        "FSGS"
      ],
      "diagnosis": "Kidney biopsy, blood tests, and genetic testing.",
      "treatment": "Supportive care, immunosuppressive therapy, and complement inhibitors; dialysis or kidney transplant for advanced disease.",
      "clinical_trials": [
        "NCT03620009",
        "NCT03114998"
      ],
      "key_aspects": [
        "Rarity and heterogeneity",
        "Risk of progression to kidney failure"
      ]
    }
  ]
}